AR221851A1 - Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina - Google Patents
Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolinaInfo
- Publication number
- AR221851A1 AR221851A1 AR274310A AR27431078A AR221851A1 AR 221851 A1 AR221851 A1 AR 221851A1 AR 274310 A AR274310 A AR 274310A AR 27431078 A AR27431078 A AR 27431078A AR 221851 A1 AR221851 A1 AR 221851A1
- Authority
- AR
- Argentina
- Prior art keywords
- dialcoxy
- piperidine
- procedure
- preparation
- quinazoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4566977 | 1977-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR221851A1 true AR221851A1 (es) | 1981-03-31 |
Family
ID=10438111
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR274310A AR221851A1 (es) | 1977-11-03 | 1978-11-01 | Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina |
| AR278733A AR221251A1 (es) | 1977-11-03 | 1979-11-01 | Un procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR278733A AR221251A1 (es) | 1977-11-03 | 1979-11-01 | Un procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4188391A (it) |
| JP (1) | JPS5498786A (it) |
| AR (2) | AR221851A1 (it) |
| AT (1) | AT366043B (it) |
| AU (1) | AU506317B2 (it) |
| BE (1) | BE871769A (it) |
| CA (1) | CA1086735A (it) |
| CH (1) | CH637130A5 (it) |
| DE (1) | DE2847622A1 (it) |
| DK (1) | DK488078A (it) |
| ES (2) | ES474763A1 (it) |
| FI (1) | FI63934C (it) |
| FR (1) | FR2407926A1 (it) |
| HK (1) | HK94184A (it) |
| IE (1) | IE47996B1 (it) |
| IL (1) | IL55845A (it) |
| IT (1) | IT1101287B (it) |
| KE (1) | KE3351A (it) |
| LU (1) | LU80461A1 (it) |
| MY (1) | MY8500284A (it) |
| NL (1) | NL174144C (it) |
| PH (1) | PH14693A (it) |
| PT (1) | PT68733A (it) |
| SE (1) | SE7811323L (it) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4489075A (en) * | 1982-05-15 | 1984-12-18 | Pfizer Inc. | Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants |
| JPS61215389A (ja) * | 1985-03-20 | 1986-09-25 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体およびそれを含有する強心剤 |
| US5614627A (en) * | 1993-09-10 | 1997-03-25 | Eisai Co., Ltd. | Quinazoline compounds |
| AU3784997A (en) * | 1996-08-09 | 1998-03-06 | Eisai Co. Ltd. | Benzopiperidine derivatives |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| WO2007104035A1 (en) * | 2006-03-08 | 2007-09-13 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| EP2068872A1 (en) * | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| AU2007299920A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | PPAR Mediated Modulation of Neurogenesis |
| CN101522662A (zh) * | 2006-10-06 | 2009-09-02 | 博士伦公司 | 喹诺酮羧酸、其衍生物、及其制备方法和其用作抗菌剂的用途 |
| US7632944B2 (en) * | 2007-01-24 | 2009-12-15 | Bausch & Lomb Incorporated | Quinolone carboxylic acids, derivatives thereof, and methods of making and using same |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| WO2020190912A1 (en) | 2019-03-19 | 2020-09-24 | Stingray Therapeutics, Inc. | Quinoline and quinazoline compounds and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1199768A (en) * | 1966-10-31 | 1970-07-22 | Pfizer & Co C | Nitrogen Heterocycles and process for their preparation |
| US3812127A (en) * | 1966-10-31 | 1974-05-21 | Pfizer | 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters |
| US3517005A (en) * | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
| GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
-
1978
- 1978-10-24 CA CA314,062A patent/CA1086735A/en not_active Expired
- 1978-10-26 US US05/954,931 patent/US4188391A/en not_active Expired - Lifetime
- 1978-10-30 PH PH21751A patent/PH14693A/en unknown
- 1978-10-31 LU LU80461A patent/LU80461A1/fr unknown
- 1978-11-01 IL IL55845A patent/IL55845A/xx unknown
- 1978-11-01 AR AR274310A patent/AR221851A1/es active
- 1978-11-01 NL NLAANVRAGE7810865,A patent/NL174144C/xx not_active IP Right Cessation
- 1978-11-01 SE SE7811323A patent/SE7811323L/xx unknown
- 1978-11-01 CH CH1125378A patent/CH637130A5/de not_active IP Right Cessation
- 1978-11-01 FI FI783325A patent/FI63934C/fi not_active IP Right Cessation
- 1978-11-01 DK DK488078A patent/DK488078A/da not_active Application Discontinuation
- 1978-11-02 DE DE19782847622 patent/DE2847622A1/de not_active Ceased
- 1978-11-02 JP JP13569678A patent/JPS5498786A/ja active Granted
- 1978-11-02 ES ES474763A patent/ES474763A1/es not_active Expired
- 1978-11-02 FR FR7831062A patent/FR2407926A1/fr active Granted
- 1978-11-02 IT IT29368/78A patent/IT1101287B/it active
- 1978-11-02 IE IE2165/78A patent/IE47996B1/en unknown
- 1978-11-02 PT PT68733A patent/PT68733A/pt unknown
- 1978-11-02 AU AU41277/78A patent/AU506317B2/en not_active Expired
- 1978-11-02 AT AT0783878A patent/AT366043B/de not_active IP Right Cessation
- 1978-11-03 BE BE191542A patent/BE871769A/xx not_active IP Right Cessation
-
1979
- 1979-04-27 ES ES480053A patent/ES480053A1/es not_active Expired
- 1979-11-01 AR AR278733A patent/AR221251A1/es active
-
1983
- 1983-11-21 KE KE3351A patent/KE3351A/xx unknown
-
1984
- 1984-11-29 HK HK941/84A patent/HK94184A/xx unknown
-
1985
- 1985-12-30 MY MY284/85A patent/MY8500284A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IT1101287B (it) | 1985-09-28 |
| CA1086735A (en) | 1980-09-30 |
| DK488078A (da) | 1979-05-04 |
| FI63934B (fi) | 1983-05-31 |
| FI63934C (fi) | 1983-09-12 |
| FR2407926B1 (it) | 1982-11-12 |
| FI783325A (fi) | 1979-05-04 |
| NL174144C (nl) | 1984-05-01 |
| ES474763A1 (es) | 1980-12-16 |
| FR2407926A1 (fr) | 1979-06-01 |
| HK94184A (en) | 1984-12-07 |
| IL55845A0 (en) | 1979-01-31 |
| SE7811323L (sv) | 1979-05-04 |
| IE47996B1 (en) | 1984-08-22 |
| AT366043B (de) | 1982-03-10 |
| AU4127778A (en) | 1979-05-17 |
| AU506317B2 (en) | 1979-12-20 |
| PT68733A (en) | 1978-12-01 |
| AR221251A1 (es) | 1981-01-15 |
| CH637130A5 (de) | 1983-07-15 |
| PH14693A (en) | 1981-11-10 |
| ES480053A1 (es) | 1980-07-16 |
| DE2847622A1 (de) | 1979-05-31 |
| JPS566428B2 (it) | 1981-02-10 |
| LU80461A1 (fr) | 1980-05-07 |
| US4188391A (en) | 1980-02-12 |
| IL55845A (en) | 1982-07-30 |
| IT7829368A0 (it) | 1978-11-02 |
| ATA783878A (de) | 1981-07-15 |
| NL174144B (nl) | 1983-12-01 |
| NL7810865A (nl) | 1979-05-07 |
| MY8500284A (en) | 1985-12-31 |
| JPS5498786A (en) | 1979-08-03 |
| KE3351A (en) | 1983-12-16 |
| BE871769A (fr) | 1979-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX5950E (es) | Procedimiento para la preparacion de derivados de la pirrolidin-2-ona | |
| MX5527E (es) | Procedimiento para la preparacion de derivados de carboestirilo | |
| AR220004A1 (es) | Procedimiento para la preparacion de derivados de 4,4-dimetil-2-imidazolidinona | |
| ES508618A0 (es) | Procedimiento para la preparacion de derivados de la quino- lina. | |
| MX4988E (es) | Procedimiento para la preparacion de derivados pirrolidinicos | |
| MX5934E (es) | Procedimiento para la preparacion de 1-substituido-4,5-diaril-2-(tiosubstituido)imidazoles | |
| AR221851A1 (es) | Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina | |
| AR222666A1 (es) | Procedimiento para preparar derivados de 5-tetrazolil dibenzo-(b,f)tiepinas | |
| MX4664E (es) | Procedimiento mejorado para la preparacion de derivados de n-fosfonometilglicina | |
| MX5479E (es) | Procedimiento para la preparacion de derivados de 1-oxadetiacefalosporinas | |
| MX5256E (es) | Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina | |
| AR217688A1 (es) | Procedimiento para la preparacion de derivados de trans-2-sustituido-5-aril-2,3,4,4a,5,9b-hexahidro-1h-pirido(4,3-b)-indol | |
| AR218296A1 (es) | Procedimiento para la preparacion de nuevos derivados de 14-beta-amino-morfina | |
| ES494291A0 (es) | Procedimiento para la preparacion de derivados diazoicos. | |
| MX4884E (es) | Procedimiento para la preparacion de derivados de la tienopiridina | |
| AR223465A1 (es) | Procedimiento para obtener derivados de 5-bencil-2,4-diamino-pirimidinas | |
| AR221215A1 (es) | Procedimiento para la preparacion de cloroacetanilidas substituidas | |
| MX6009E (es) | Procedimiento para la preparacion de tetrahidro-1,3,5-tiadiazin-4-onas | |
| AR230835A1 (es) | Procedimiento para la obtencion de derivados de 2,1,3-tiadiazin-4-ona-2,2-dioxido | |
| ES494211A0 (es) | Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos. | |
| MX4991E (es) | Procedimiento para la preparacion de 2,4,diamino-5-tiobencilpirimidinas | |
| MX5454E (es) | Procedimiento para preparar derivados de la 1,2,4-triazin-5-ona | |
| MX5620E (es) | Procedimiento mejorado para la preparacion de n-hidroxi-n-fosfonometilglicina | |
| AR220127A1 (es) | Procedimiento para la preparacion de d-homopregna-4,8-dieno-3,20-dionas | |
| AR218311A1 (es) | Procedimiento para la preparacion de derivados de fenoximetil-2-imidazolina |